Patterns of bisphosphonate treatment among patients with multiple myeloma treated at oncology clinics across the USA: observations from real-world data
Sign Up to like & getrecommendations! Published in 2018 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-018-4133-1
Abstract: PurposeCurrent guidelines recommend that intravenous bisphosphonates be initiated in all patients with multiple myeloma for management of bone disease. The objective of this study was to describe real-world bisphosphonate treatment patterns.MethodsThis was a retrospective observational… read more here.
Keywords: multiple myeloma; patients multiple; world; bisphosphonate treatment ... See more keywords
Bisphosphonate treatment in children with acute lymphoblastic leukemia and osteonecrosis – radiological and clinical findings in a national cohort
Sign Up to like & getrecommendations! Published in 2021 at "Acta Oncologica"
DOI: 10.1080/0284186x.2021.1950928
Abstract: Abstract Background: Osteonecrosis (ON) is a recognized complication of childhood ALL, but its optimal management remains unestablished. This study evaluated the effect of bisphosphonate (BP) treatment on the evolution of ON lesions in childhood ALL.… read more here.
Keywords: bisphosphonate treatment; treatment; osteonecrosis; national cohort ... See more keywords
Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Genes"
DOI: 10.3390/genes13010146
Abstract: Atypical femoral fractures (AFF) are rare fragility fractures in the subtrocantheric or diaphysis femoral region associated with long-term bisphosphonate (BP) treatment. The etiology of AFF is still unclear even though a genetic basis is suggested.… read more here.
Keywords: atypical femoral; bisphosphonate treatment; femoral fractures; treatment ... See more keywords